Janux Therapeutics Inc (JANX)

CapEx to Revenue

1.97%

Quarterly · Period ending:

JANX logo

JANX CapEx to Revenue

Latest reported1.97%
JANX Quarterly CapEx/Revenue (0.00% → 1.97%)
High-resolution chart · PNG

JANX capex to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Janux Therapeutics Inc CapEx to Revenue — Quarterly
Period endingCapEx to Revenue
1.9675%
7.3132%
0%
0.93%
0%
0%
0%
5.6948%
1.0678%
15.7348%
20.9265%
18.673%
54.8723%
13.916%
72.2671%
138.9961%
37.9704%
61.1076%
72.5866%
6.6437%
16.39%
40.2632%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.